Billionaire investor Ray Dalio says the stock market is in a bubble - but don't sell yet.
IonQ shares are sliding after a fresh JPMorgan note praised its quantum roadmap but flagged lofty valuation and downside near term.
FDA grants accelerated approval to Bayer's Hyrnuo and full approval to Amgen's Imdelltra, expanding treatment options for advanced lung cancer.
WSM posted solid quarter but stock slipped due to concerns of higher tariff costs. Analysts maintain positive outlook.
Novartis raises long-term sales targets, boosts outlook for key medicines and outlines a pipeline strategy driving growth through 2030.
Shares of Moderna are falling Thursday. The company made two significant announcements regarding its finances and business strategy.
Citizens analysts assume coverage and rate IREN, Cipher, Nebius, Riot and WhiteFiber as Market Outperform.
Palo Alto Networks, Inc. (NASDAQ:PANW) shares are trading lower Thursday on the heels of the company's fiscal first-quarter earnings results.